Holen Sie sich die Stockscreener-App
6.10
5.35%
0.31
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.90%
34.34
|
30.42 | 23.34 | 21.60 | 29.60 |
| Operating Income/Loss |
12.90%
-34.34
|
-30.42 | -23.34 | -21.60 | -29.60 |
| Nonoperating Income/Loss |
7.55%
3.369
|
3.644 | 1.84 | 1.506 | 1.316 |
| Income/Loss From Continuing Operations Before Tax |
15.69%
-30.97
|
-26.77 | -21.50 | -20.09 | -28.29 |
| Income/Loss From Continuing Operations After Tax |
15.68%
-30.97
|
-26.77 | -21.50 | -20.09 | -28.29 |
|
Net Income/Loss
|
15.68%
-30.97
|
-26.77 | -21.50 | -20.09 | -28.29 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,611%
55.57
|
3.2471 | 44.98 | 40.72 | 40.35 |
| Diluted Average Shares |
1,611%
55.57
|
3.2471 | 44.98 | 40.72 | 40.35 |
| Basic Earnings Per Share |
16.67%
-0.56
|
-0.48 | -0.48 | -0.49 | -0.70 |
| Diluted Earnings Per Share |
16.67%
-0.56
|
-0.48 | -0.48 | -0.49 | -0.69 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):